Ken Griffin Rani Therapeutics Holdings, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 7,400 shares of RANI stock, worth $28,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,400Holding current value
$28,120% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding RANI
# of Institutions
42Shares Held
3.18MCall Options Held
38.3KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA685KShares$2.6 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$1.88 Million1.52% of portfolio
-
United Services Automobile Association San Antonio, TX481KShares$1.83 Million0.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$1.7 Million0.06% of portfolio
-
Stifel Financial Corp St. Louis, MO132KShares$503,2490.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $93.1M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...